Medtronic Neuromodulation
Company · Minneapolis, Minnesota, USA
Leader in deep brain stimulation; its Percept devices can also sense brain signals and adjust stimulation automatically.
Medtronic’s DBS systems have treated hundreds of thousands of people with Parkinson’s disease, essential tremor, dystonia and epilepsy. Its BrainSense technology records local field potentials from the implanted leads. Adaptive (closed-loop) DBS is one of the first “read-and-write” neural interfaces in routine care.
In the news
Medtronic to acquire SPR Therapeutics for about $650 million
SPR's SPRINT PNS is a 60-day peripheral nerve stimulation therapy for pain that doesn't require a permanent implant.
Precision Neuroscience and Medtronic partner to combine a BCI with surgical navigation
The companies will integrate Precision's Layer 7 surface interface with Medtronic's StealthStation for real-time brain mapping during surgery.
After 22 years, Medtronic's DBS gains full FDA approval for dystonia
Deep brain stimulation for dystonia moves from humanitarian exemption to full effectiveness labeling, including patients 12 and older.